Cellular distributions of molecules with altered expression specific to thyroid proliferative lesions developing in a rat thyroid carcinogenesis model

Cancer Science

Volumn 100, Issue 4, 2009, Pages 617-625

  Woo, Gye Hyeong ^a   Takahashi, Miwa ^a   Inoue, Kaoru ^a   Fujimoto, Hitoshi ^a   Igarashi, Katsuhide ^a   Kanno, Jun ^a   Hirose, Masao ^a,b   Nishikawa, Akiyoshi ^a   Shibutani, Makoto ^a,c  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b Food Safety Commission of Japan   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CELL DIVISION CYCLE 2 HOMOLOG A PROTEIN; CERULOPLASMIN; CYCLIN B1; INHIBITOR OF DIFFERENTIATION 3; POLIOVIRUS RECEPTOR RELATED 3; SULFADIMETHOXINE; THYROGLOBULIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; BIS(2 HYDROXYPROPYL)NITROSAMINE; CADHERIN; CELL ADHESION MOLECULE; CYCLIN B; ID3 PROTEIN, RAT; INHIBITOR OF DIFFERENTIATION PROTEIN; NECTINS; NITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL CYCLE M PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DOWN REGULATION; EXPERIMENTAL RAT; FOCAL FOLLICULAR CELL HYPERPLASIA; GENE EXPRESSION; GENE EXPRESSION PROFILING; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; THYROID ADENOMA; THYROID CANCER; THYROID CARCINOGENESIS; THYROID CARCINOMA; THYROID FOLLICLE CELL; TUMOR GROWTH; UNINDEXED SEQUENCE; UPREGULATION; ADENOMA; ANIMAL; CELL TRANSFORMATION; DISEASE MODEL; DNA MICROARRAY; DRUG EFFECT; FISCHER 344 RAT; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; THYROID GLAND; THYROID TUMOR;

ADENOMA; ANIMALS; CADHERINS; CELL ADHESION MOLECULES; CELL TRANSFORMATION, NEOPLASTIC; CERULOPLASMIN; CYCLIN B; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEINS; MALE; NITROSAMINES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; SULFADIMETHOXINE; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS;

EID: 67449084327     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01094.x     Document Type: Article

References (48)

1. Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: Management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 2001; 7: 202-20.
2. Schneider AB, Sarne DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Pract Endocrinol Metab 2005; 1: 82-91.
3. Kitahori Y, Hiasa Y, Konishi N, Enoki N, Shimoyama T, Miyashiro A. Effect of propylthiouracil on the thyroid tumorigenesis induced by N-bis (2-hydroxypropyl) nitrosamine in rats. Carcinogenesis 1984; 5: 657-60.
4. Jemec B. Studies of the goitrogenic and tumorigenic effect of two goitrogens in combination with hypophysectomy or thyroid hormone treatment. Cancer 1980; 45: 2138-48.
5. Hiasa Y, Ohshima M, Kitahori Y, Yuasa T, Fujita T, Iwata C. Promoting effects of 3-amino-1,2,4-triazole on the development of thyroid tumors in rats treated with N-bis (2-hydroxypropyl) nitrosamine. Carcinogenesis 1982; 3: 381-4.
6. Hard GC. Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis. Environ Health Perspect 1998; 106: 427-36.
7. Smith P, Williams ED, Wynford-Thomas D. In.vitro demonstration of a TSH-specific growth desensitising mechanism in rat thyroid epithelium. Mol Cell Endocrinol 1987; 51: 51-8.
8. Brewer C, Yeager N, Di Cristofano A. Thyroid-stimulating hormone initiated proliferative signals converge in.vivo on the mTOR kinase without activating AKT. Cancer Res 2007; 67: 8002-6.
9. Mitsumori K, Onodera H, Takahashi M et al. Effect of thyroid stimulating hormone on the development and progression of rat thyroid follicular cell tumors. Cancer Lett 1995; 92: 193-202.
10. Roy G, Mugesh G. Bioinorganic chemistry in thyroid gland: Effect of antithyroid drugs on peroxidase-catalyzed oxidation and iodination reactions. Bioinorg Chem Appl 2006; 2006: 23214.
11. Shibutani M, Uneyama C, Miyazaki K, Toyoda K, Hirose M. Methacarn fixation: A novel tool for analysis of gene expressions in paraffin-embedded tissue specimens. Lab Invest 2000; 80: 199-208.
12. Uneyama C, Shibutani M, Masutomi N, Takagi H, Hirose M. Methacarn fixation for genomic DNA analysis in microdissected, paraffin-embedded tissue specimens. J Histochem Cytochem 2002; 50: 1237-45.
13. Takagi H, Shibutani M, Kato N et al. Microdissected region-specific gene expression analysis with methacarn-fixed, paraffin-embedded tissues by real-time RT-PCR. J Histochem Cytochem 2004; 52: 903-13.
14. Takagi H, Shibutani M, Lee KY et al. Impact of maternal dietary exposure to endocrine-acting chemicals on progesterone receptor expression in microdissected hypothalamic medial preoptic areas of rat offspring. Toxicol Appl Pharmacol 2005; 208: 127-36.
15. Shibutani M, Lee KY, Igarashi K et al. Hypothalamus region-specific global gene expression profiling in early stages of central endocrine disruption in rat neonates injected with estradiol benzoate or flutamide. Dev Neurobiol 2007; 67: 253-69.
16. Lee KY, Shibutani M, Inoue K, Kuroiwa KUM, Woo GH, Hirose M. Methacarn fixation - effects of tissue processing and storage conditions on detection of mRNAs and proteins in paraffin-embedded tissues. Anal Biochem 2006; 351: 36-43.
17. Hardisty JF, Boorman GA. Thyroid gland. In: Boorman GA, Eustis SL, Elwell MR, Montgomery CA Jr, MacKenzie WF, eds. Pathology of the Fischer Rat, Reference and Atlas. San Diego: Academic Press, 1990: 519-36.
18. Imai T, Onose J, Hasumura M, Ueda M, Takizawa T, Hirose M. Sequential analysis of development of invasive thyroid follicular cell carcinomas in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis (2-hydroxypropyl) nitrosamine-initiation. Toxicol Pathol 2004; 32: 229-36.
19. Goldstein IM, Kaplan HB, Edelson HS, Weissmann G. Ceruloplasmin. A scavenger of superoxide anion radicals. J Biol Chem 1979; 254: 4040-5.
20. Lin JD. Thyroglobulin and human thyroid cancer. Clin Chim Acta 2008; 388: 15-21.
21. Ziak M, Meier M, Novak-Hofer I, Roth J. Ceruloplasmin carries the anionic glycan oligo/poly α2,8 deaminoneuraminic acid. Biochem Biophys Res Commun 2002; 295: 597-602.
22. Scott IS, Morris LS, Bird K et al. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: Implications for the prediction of outcome in colorectal cancer. J Pathol 2003; 201: 187-97.
23. Yamamoto H, Monden T, Ikeda K et al. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 1995; 71: 1231-6.
24. Faggiano A, Caillou B, Lacroix L et al. Functional characterization of human thyroid tissue with immunohistochemistry. Thyroid 2007; 17: 203-11.
25. Kuramitsu K, Ikeda W, Inoue N, Tamaru Y, Takai Y. Novel role of nectin: implication in the co-localization of JAM-A and claudin-1 at the same cell-cell adhesion membrane domain. Genes Cells 2008; 13: 797-805.
26. Carroll M, Hamzeh M, Robaire B. Expression, localization, and regulation of inhibitor of DNA binding (Id) proteins in the rat epididymis. J Androl 2006; 27: 212-24.
27. Lelkes PI, Hahn KL, Sukovich DA, Karmiol S, Schmidt DH. On the possible role of reactive oxygen species in angiogenesis. Adv Exp Med Biol 1998; 454: 295-310.
28. Suh YA, Arnold RS, Lassegue B et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401: 79-82.
29. Stassar MJ, Devitt G, Brosius M et al. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer 2001; 85: 1372-82.
30. Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ. Coordinately up-regulated genes in ovarian cancer. Cancer Res 2001; 61: 3869-76.
31. Wang KK, Liu N, Radulovich N et al. Novel candidate tumor marker genes for lung adenocarcinoma. Oncogene 2002; 21: 7598-604.
32. Tuccari G, Barresi G. Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas. Histopathology 1987; 11: 723-31.
33. Song B. Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases. Acta Pathol Jpn 1991; 41: 336-43.
34. Kondi-Pafiti A, Smyrniotis V, Frangou M, Papayanopoulou A, Englezou M, Deligeorgi H. Immunohistochemical study of ceruloplasmin, lactoferrin and secretory component expression in neoplastic and non-neoplastic thyroid gland diseases. Acta Oncol 2000; 39: 753-6.
35. Draetta G, Luca F, Westendorf J, Brizuela L, Ruderman J, Beach D. cdc2 protein kinase is complexed with both cyclin A and B. Evidence for proteolytic inactivation of MPF. Cell 1989; 56: 829-38.
36. Chen H, Huang Q, Dong J, Zhai DZ, Wang AD, Lan Q. Overexpression of CDC2/ CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in.vitro and in.vivo. BMC Cancer 2008; 8: 29.
37. Wiseman SM, Griffith OL, Deen S et al. Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Arch Surg 2007; 142: 717-29.
38. Simmons DL. Dissecting the modes of interactions amongst cell adhesion molecules. Dev Suppl 1993; ???: 193-203.
39. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 1998; 280: 1618-20.
40. Nelson GM, Padera TP, Garkavtsev I, Shioda T, Jain RK. Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells. Neoplasia 2007; 9: 1038-45.
41. Takai Y, Miyoshi J, Ikeda W, Ogita H. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 2008; 9: 603-15.
42. Murakami Y. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci 2005; 96: 543-52.
43. Wakayama T, Sai Y, Ito A et al. Heterophilic binding of the adhesion molecules poliovirus receptor and immunoglobulin superfamily 4A in the interaction between mouse spermatogenic and Sertoli cells. Biol Reprod 2007; 76: 1081-90.
44. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id. A negative regulator of helix-loop-helix DNA binding proteins. Cell 1990; 61: 49-59.
45. Ellis HM, Spann DR, Posakony JW. Extramacrochaetae, a negative regulator of sensory organ development in Drosophila, defines a new class of helix-loop-helix proteins. Cell 1990; 61: 27-38.
46. Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell 2003; 3: 525-30.
47. Arnold JM, Mok SC, Purdie D, Chenevix-Trench G. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas. Br J Cancer 2001; 84: 352-9.
48. Nikolova DN, Zembutsu H, Sechanov T et al. Genome-wide gene expression profiles of thyroid carcinoma: Identification of molecular targets for treatment of thyroid carcinoma. Oncol Rep 2008; 20: 105-21.